Sanofi | SNY - Operating Profit




Sanofi reported EUR3.64B in Operating Profit for its fiscal quarter ending in September of 2024.

Operating Profit Change Date
AbbVie USD -1490000000 5.4B Dec/2024
Amgen USD 2.31B 264M Dec/2024
AstraZeneca USD 2.04B 731M Dec/2024
Bristol-Myers Squibb USD 510M 1.66B Dec/2024
Canopy Growth CAD -45623000 24.31M Sep/2024
Corcept Therapeutics USD 46.6M 11.01M Sep/2024
Drreddys Laboratories INR 17.55B 374M Sep/2024
Eli Lilly USD 5.15B 714.4M Dec/2024
Galapagos EUR -62720000 8.41M Dec/2024
Genmab DKK 2.19B 89M Dec/2024
GlaxoSmithKline GBP 696M 507M Dec/2024
Glaxosmithkline GBP 667M 979M Sep/2024
Indivior 94M 226M Sep/2024
J&J USD 3.89B 549M Dec/2024
Merck USD 4.22B 266M Dec/2024
Novartis USD 2.28B 1.34B Dec/2024
Novartis USD 4.44B 415M Sep/2024
Pacira USD -139527000 170.51M Sep/2024
Perrigo USD 75.3M 30.3M Sep/2024
Pfizer USD -409000000 5.69B Dec/2024
Prestige Brands USD 91.96M 7.62M Dec/2024
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 4.09B 1.81B Sep/2024
Sanofi EUR 3.64B 1.35B Sep/2024
Supernus Pharmaceuticals USD 40.84M 22.63M Sep/2024
UCB EUR 163M 39M Jun/2024
Zoetis USD 732M 675M Dec/2024